SI-BONE, Inc. — Director's Dealing 2023

Aug 18, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SI-BONE, Inc. (SIBN)
CIK: 0001459839
Period of Report: 2023-08-16

Reporting Person: RECUPERO ANTHONY J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-08-16	Common Stock	S	1610.00	$21.0023	Disposed	217880.00	Direct
2023-08-16	Common Stock	S	2075.00	$20.9625	Disposed	215805.00	Direct
2023-08-16	Common Stock	S	306.00	$21.0457	Disposed	215499.00	Direct
2023-08-16	Common Stock	S	1468.00	$20.9763	Disposed	214031.00	Direct
2023-08-16	Common Stock	S	26.00	$21.26	Disposed	214005.00	Direct
2023-08-17	Common Stock	S	2997.00	$21.07	Disposed	211008.00	Direct

Footnotes

F1: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2: This transaction was executed in multiple trades at prices ranging from $20.75 USD to $21.12 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: This transaction was executed in multiple trades at prices ranging from $20.75 USD to $21.13 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F4: This transaction was executed in multiple trades at prices ranging from $21.045 USD to $21.08 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5: This transaction was executed in multiple trades at prices ranging from $20.80 USD to $21.14 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F7: The shares were sold in multiple transactions ranging from $20.64 to $21.30 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: Includes 141,037 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.